Sign In
Buy ALKS
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026
Journal of Clinical Psychiatry Publishes Data from Alkermes' ALPINE Study in Patients With Schizophrenia
11:00am, Wednesday, 20'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced that data from its phase 3b ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation Effectiveness) study were published in the Journal of Clini
Krensavage Asset Management, LLC Buys Alexion Pharmaceuticals Inc, Enanta Pharmaceuticals Inc, ...
12:00am, Monday, 18'th May 2020Alkermes To Present New Data From Schizophrenia Portfolio At SIRS Meeting
11:15am, Thursday, 14'th May 2020Alkermes Presents New Data From Schizophrenia Portfolio at Virtual 2020 Congress of the Schizophrenia International Research Society
11:00am, Thursday, 14'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced the presentation of new data from its schizophrenia portfolio as part of the virtual 2020 Congress of the Schizophrenia International Research Society (SIRS
Alkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $–.– million of Shares
12:00am, Thursday, 14'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced the expansion of several programs and services in support of patient access to its proprietary medicines during the COVID-19 crisis. During this unprecedent
Alkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $7'–,5…… of Shares
12:00am, Thursday, 07'th May 2020Alkermes Announces Upcoming Presentation at the Bank of America Securities Virtual Health Care Conference
08:00pm, Wednesday, 06'th May 2020
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 2020 Bank of America Securities Virtual Health Care Conference on Wednesday, May 13, 2020 at 9:40
Johnston Asset Management Corp Buys Boston Scientific Corp, Albemarle Corp, Prologis Inc, Sells ...
12:00am, Monday, 04'th May 2020Analysts Have Lowered Expectations For Alkermes plc (NASDAQ:ALKS) After Its Latest Results
01:45pm, Friday, 01'st May 2020
Alkermes plc (NASDAQ:ALKS) just released its first-quarter report and things are looking bullish. Revenues and losses...
Easy Come, Easy Go: How Alkermes (NASDAQ:ALKS) Shareholders Got Unlucky And Saw 76% Of Their Cash Evaporate
10:03am, Friday, 01'st May 2020
It's not possible to invest over long periods without making some bad investments. But you want to avoid the really...
Alkermes' (ALKS) Q1 Earnings Increase Y/Y, Revenues Beat
03:12pm, Thursday, 30'th Apr 2020
Alkermes (ALKS) beats earnings and sales estimates for the first quarter of 2020. The company withdraws its previously provided outlook for 2020 amid uncertainty related to coronavirus.
Alkermes' (ALKS) Q1 Earnings Increase Y/Y, Revenues Beat
03:12pm, Thursday, 30'th Apr 2020
Alkermes (ALKS) beats earnings and sales estimates for the first quarter of 2020. The company withdraws its previously provided outlook for 2020 amid uncertainty related to coronavirus.
